India is ranked amongst the top 12 biotech destinations in the world - and is ranked second to China in Asia. It is the largest producer in the world of the recombinant Hepatitis B vaccine. Five segments presently constitute the Indian bio-technology sector - bio-services, bio pharmaceuticals, bio-industrial, bio-agriculture, and bio-informatics.
The segment of bio-pharma forms 60 per cent of total revenues in India's biotechnology sector. As per data available with the Department of Industrial Policy and Promotion, the Indian drugs and pharmaceutical sector recorded FDI worth 3.2 billion dollars between April 2011 and January 2012.
The most popular citizen journalists' reports on merinews chosen automatically on the basis of views and comments